Chambers Review
Provided by Chambers
Life Sciences - USA - Nationwide
What the Team is Known For
Notable practitioners
David Dykeman and Wayne Elowe are co-chairs of the practice and key contacts.
Provided by Greenberg Traurig, LLP
Greenberg Traurig's Life Sciences & Medical Technology Group comprises attorneys with multidisciplinary and practical skills, aiding clients in diverse technologies and product solutions. Start-ups, large multinational public companies, research organizations, and not-for-profit care providers, as well as investors, venture capital funds, and public agencies, look to us to guide them from discovery through commercialization and product marketing. Our team is positioned to provide innovative and informed legal advice with the combined experience of the firm’s health care, intellectual property, governmental affairs, regulatory, corporate, real estate, litigation, products liability, and employment professionals. We handle transactional and litigation matters and representation before administrative and regulatory agencies, and frequently advise on FDA-related matters. Together, our attorneys and governmental professionals help our clients advance their products from the lab to the marketplace.
Provided by Chambers
David Dykeman and Wayne Elowe are co-chairs of the practice and key contacts.
Greenberg Traurig, LLP represented 89bio, Inc., its its $3.5 billion acquisition by Roche.
Provided by Chambers
Greenberg Traurig has numerous PhD attorneys and patent agents that are well versed in our technology.
They are proactive, client-specific and offer detail-oriented services.
Greenberg Traurig has numerous PhD attorneys and patent agents that are well versed in our technology.
They are proactive, client-specific and offer detail-oriented services.
Provided by Greenberg Traurig, LLP

Head of Department
Wayne H. Elowe
Head of Department